Presentation is loading. Please wait.

Presentation is loading. Please wait.

Survival benefits of revascularization in patients with critical limb ischemia and renal insufficiency  Jana Ortmann, MD, Brigitta Gahl, MD, Nicolas Diehm,

Published bySpencer Thornton Modified over 5 years ago

Similar presentations

Presentation on theme: "Survival benefits of revascularization in patients with critical limb ischemia and renal insufficiency  Jana Ortmann, MD, Brigitta Gahl, MD, Nicolas Diehm,"— Presentation transcript:

1 Survival benefits of revascularization in patients with critical limb ischemia and renal insufficiency  Jana Ortmann, MD, Brigitta Gahl, MD, Nicolas Diehm, MD, Florian Dick, MD, Tobias Traupe, MD, Iris Baumgartner, MD  Journal of Vascular Surgery  Volume 56, Issue 3, Pages e1 (September 2012) DOI: /j.jvs Copyright © 2012 Society for Vascular Surgery Terms and Conditions

2 Fig 1 Hazard ratios from univariable (left) and hazard ratios and forest plots from multivariable analysis (right). Cox proportional hazard models compare the effects of revascularization vs medical therapy on (A) amputation-free survival and (B) overall survival separately for all critical limb ischemia (CLI) patients, and for CLI patients with absent/mild renal insufficiency (RI), moderate RI, and severe RI, respectively. Multivariable Cox models were adjusted for age, sex, diabetes, hypertension, and smoking. P values were calculated using the two-sided Wald test derived from Cox-proportional hazard models. GFR, Glomerular filtration rate. Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

3 Fig 2 Kaplan-Meier survival curves for cumulative outcome estimates of primary efficacy study end points for (A, C, and E) amputation-free survival and (B, D, and F) overall survival calculated separately for revascularization and medical therapy (MT) for critical limb ischemia (CLI) patients with (A and B) absent/mild renal insufficiency (RI), (C and D) moderate RI, and (E and F) severe renal insufficiency, respectively. P values were calculated using χ2 test derived from Cox proportional hazard models. Numbers at risk are given for patients. GFR, Glomerular filtration rate. Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

4 Fig. 3 Hazard ratios from univariable (left) and hazard ratios and forest plots from multivariable analysis (right). Cox proportional hazard models to compare the effects of revascularization vs medical therapy (MT) on (A) clinical success and (B) limb salvage separately for all critical limb ischemia (CLI) patients, and for CLI patients with absent/mild renal insufficiency (RI), moderate RI, and severe RI, respectively. Multivariable Cox models were adjusted for age, sex, diabetes, hypertension, and smoking. P values were calculated using two-sided Wald test derived from Cox-proportional hazard models. *In the severe RI group, coefficients did not converge because of complete separation and low patient numbers. The bivariable analysis yielded P = .309 (Fisher exact test) with six amputations, all in the immediate revascularization group. GFR, Glomerular filtration rate. Journal of Vascular Surgery  , e1DOI: ( /j.jvs ) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Download ppt "Survival benefits of revascularization in patients with critical limb ischemia and renal insufficiency  Jana Ortmann, MD, Brigitta Gahl, MD, Nicolas Diehm,"

Similar presentations

The progressive nature of peripheral arterial disease in young adults: A prospective analysis of white men referred to a vascular surgery service  R.James.

The progressive nature of peripheral arterial disease in young adults: A prospective analysis of white men referred to a vascular surgery service  R.James.
Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia  Vincent Ziza, MD, Ludovic Canaud, MD, PhD, Thomas.

Outcomes of cold-stored venous allograft for below-knee bypasses in patients with critical limb ischemia  Vincent Ziza, MD, Ludovic Canaud, MD, PhD, Thomas.
Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia  Jayer Chung, MD, J. Gregory Modrall, MD, Chul.

Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia  Jayer Chung, MD, J. Gregory Modrall, MD, Chul.
Min-Woong Sohn, PhD, Judith L. Meadows, MD, Elissa H

Min-Woong Sohn, PhD, Judith L. Meadows, MD, Elissa H
Endovascular therapy for acute limb ischemia

Endovascular therapy for acute limb ischemia
The prognosis of patients on hemodialysis with foot lesions

The prognosis of patients on hemodialysis with foot lesions
Revascularization for acute mesenteric ischemia

Revascularization for acute mesenteric ischemia
Malachi G. Sheahan, MD, Allen D. Hamdan, MD, Jennifer R

Malachi G. Sheahan, MD, Allen D. Hamdan, MD, Jennifer R
Jason T. Lee, MD, Vinit N. Varu, MD, Kenneth Tran, BS, Ronald L

Jason T. Lee, MD, Vinit N. Varu, MD, Kenneth Tran, BS, Ronald L
Benefit of immediate revascularization in women with critical limb ischemia in an intention-to-treat analysis  Jana Ortmann, MD, Eveline Nüesch, PhD,

Benefit of immediate revascularization in women with critical limb ischemia in an intention-to-treat analysis  Jana Ortmann, MD, Eveline Nüesch, PhD,
Smoking cessation is associated with decreased mortality and improved amputation- free survival among patients with symptomatic peripheral artery disease 

Smoking cessation is associated with decreased mortality and improved amputation- free survival among patients with symptomatic peripheral artery disease 
Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization 

Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization 
Early and long-term results of carotid endarterectomy in diabetic patients  Walter Dorigo, MD, Raffaele Pulli, MD, Giovanni Pratesi, MD, Aaron Fargion,

Early and long-term results of carotid endarterectomy in diabetic patients  Walter Dorigo, MD, Raffaele Pulli, MD, Giovanni Pratesi, MD, Aaron Fargion,
Jayer Chung, MD, David A. Timaran, MD, J

Jayer Chung, MD, David A. Timaran, MD, J
Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization  Peter A. Soden, MD, Sara L. Zettervall, MD, MPH,

Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization  Peter A. Soden, MD, Sara L. Zettervall, MD, MPH,
Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions  Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions  Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,
Refinement of survival prediction in patients undergoing lower extremity bypass surgery: Stratification by chronic kidney disease classification  Christopher.

Refinement of survival prediction in patients undergoing lower extremity bypass surgery: Stratification by chronic kidney disease classification  Christopher.
Revascularization for chronic critical lower limb ischemia in octogenarians is worthwhile  Philippe Brosi, MD, Florian Dick, MD, Dai Do Do, MD, Juerg Schmidli,

Revascularization for chronic critical lower limb ischemia in octogenarians is worthwhile  Philippe Brosi, MD, Florian Dick, MD, Dai Do Do, MD, Juerg Schmidli,
Surgical or endovascular revascularization in patients with critical limb ischemia: Influence of diabetes mellitus on clinical outcome  Florian Dick,

Surgical or endovascular revascularization in patients with critical limb ischemia: Influence of diabetes mellitus on clinical outcome  Florian Dick,
Elevated serum cystatin C level is an independent predictor of contrast-induced nephropathy and adverse outcomes in patients with peripheral artery disease.

Elevated serum cystatin C level is an independent predictor of contrast-induced nephropathy and adverse outcomes in patients with peripheral artery disease.

Similar presentations

Ads by Google